Document is current
Any future updates will be listed below
-
Authors
Fenizia, Francesca
Wolstenholme, Nicola
Fairley, Jennifer A.
Rouleau, Etienne
Cheetham, Melanie H.
Horan, Martin P.
Torlakovic, Emina
Besse, Benjamin
Al Dieri, Raed
Tiniakos, Dina G.
Deans, Zandra C.
Patton, Simon J.
Normanno, Nicola https://orcid.org/0000-0002-7158-2605
-
Funding
Funding for this research was provided by:
Illumina
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck KGaA
Roche
Qiagen
ThermoFisher Scientific
- License Information
-
More Information
Article History
Received: 22 July 2020
Revised: 15 March 2021
Accepted: 30 March 2021
First Online: 15 April 2021
Declarations
:
: Nicola Normanno received research grants/personal fees from Amgen, Astrazeneca, Bayer, Biocartis, BMS, Boehringer Ingelheim, Illumina, Incyte, MERCK, MSD, Qiagen, Roche, ThermoFisher, Sanofi.Francesca Fenizia is an employee of ThermoFisher from March 2020.Benjamin Besse declares the following Sponsored Research at Gustave Roussy Cancer Center: Abbvie, Amgen, AstraZeneca, BeiGene, Blueprint Medicines, BMS, Boehringer Ingelheim, Celgene, Cristal Therapeutics, Daiichi-Sankyo, Eli Lilly, GSK, Ignyta, IPSEN, Inivata, Janssen, Merck KGaA, MSD, Nektar, Onxeo, OSE immunotherapeutics, Pfizer, Pharma Mar, Roche-Genentech, Sanofi, Servier, Spectrum Pharmaceuticals, Takeda, Tiziana Pharma, Tolero Pharmaceuticals.The other authors do not declare any conflict of interest.
